| __timestamp | Biogen Inc. | Ligand Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 2232342000 | 22570000 |
| Thursday, January 1, 2015 | 2113100000 | 24378000 |
| Friday, January 1, 2016 | 1947900000 | 26621000 |
| Sunday, January 1, 2017 | 1935500000 | 28653000 |
| Monday, January 1, 2018 | 2106300000 | 37734000 |
| Tuesday, January 1, 2019 | 2374700000 | 41884000 |
| Wednesday, January 1, 2020 | 2504500000 | 64435000 |
| Friday, January 1, 2021 | 2674300000 | 57483000 |
| Saturday, January 1, 2022 | 2403600000 | 70062000 |
| Sunday, January 1, 2023 | 2549700000 | 52790000 |
| Monday, January 1, 2024 | 2403700000 |
Cracking the code
In the competitive world of biotechnology, managing operational costs is crucial for sustained growth. Biogen Inc. and Ligand Pharmaceuticals Incorporated, two prominent players, showcase contrasting strategies in their Selling, General, and Administrative (SG&A) expenses over the past decade.
From 2014 to 2023, Biogen's SG&A expenses have seen a steady increase, peaking in 2021 with a 38% rise from 2014. This reflects their aggressive investment in marketing and administrative capabilities. In contrast, Ligand Pharmaceuticals, with a more modest SG&A budget, has shown a 133% increase over the same period, indicating a strategic shift towards expanding their operational footprint.
This analysis highlights the diverse approaches within the biotech sector, where Biogen's robust spending aligns with its expansive market strategy, while Ligand's leaner model suggests a focus on strategic growth and efficiency.
Biogen Inc. vs CymaBay Therapeutics, Inc.: SG&A Expense Trends
Biogen Inc. vs Bausch Health Companies Inc.: SG&A Expense Trends
Biogen Inc. and MannKind Corporation: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Biogen Inc. vs Novavax, Inc.
Biogen Inc. and BioCryst Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Dr. Reddy's Laboratories Limited and Ligand Pharmaceuticals Incorporated: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Walgreens Boots Alliance, Inc. vs Ligand Pharmaceuticals Incorporated Trends and Insights
Cost Management Insights: SG&A Expenses for Opthea Limited and Ligand Pharmaceuticals Incorporated
SG&A Efficiency Analysis: Comparing Ligand Pharmaceuticals Incorporated and Geron Corporation
Who Optimizes SG&A Costs Better? Ligand Pharmaceuticals Incorporated or Amphastar Pharmaceuticals, Inc.
Selling, General, and Administrative Costs: Ligand Pharmaceuticals Incorporated vs Travere Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Ligand Pharmaceuticals Incorporated and MiMedx Group, Inc.